FDA Guidance and Notices, June 2025: Cybersecurity Final Guidance and Draft Guidance on 510(k) Clearance Transfers
June was a busy month. Start with the June 27 final guidance on cybersecurity in medical devices, which covers quality system considerations and the content of premarket submissions. On June 5, FDA released draft questions and answers on transferring a 510(k) clearance.
A June 11 Federal Register notice opened comments on reauthorizing the Medical Device User Fee Amendments (MDUFA) for fiscal years 2028 through 2032, covering review performance and the fee structure. On June 24, FDA explained to health care providers the import alerts placed on certain Olympus devices made in Japan. Device classification rules were also published throughout the month.
Final guidance
- Conducting Remote Regulatory Assessments Questions and Answers (June 26): Explains how FDA carries out remote regulatory assessments (RRAs). It is an agency-wide document that also applies to device facilities.
- Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions (June 27): Covers cybersecurity within the quality system and what premarket submissions should contain. The link may now lead to a later version.
Draft guidance
- Transfer of a Premarket Notification (510(k)) Clearance – Questions and Answers (June 5): Sets out, in question-and-answer form, how a 510(k) clearance transfer is handled.
- Hernia Mesh – Package Labeling Recommendations (June 6): Recommends what information hernia mesh packaging should carry.
- Unique Device Identifier Requirements for Combination Products (June 26): Addresses how unique device identifier (UDI) requirements apply to the device constituent parts of combination products.
In the Federal Register
- Reauthorization of the Medical Device User Fee Amendments; Public Meeting; Request for Comments (June 11): Seeks comments on review performance, which programs to keep or add, and the fee structure. The public meeting was set for August 4, 2025, with comments due September 4. It is an early step toward reauthorization; no law or fee levels have been settled.
- Medical Devices; Exemptions From Premarket Notification: Class II Devices; Clinical Electronic Thermometers (June 18): Exempts Class II clinical electronic thermometers from premarket notification (510(k)), effective on publication, June 18.
- Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 064 (June 26): The update after March's List 063, adding, modifying and withdrawing recognized standards for premarket review. Each standard's scope of recognition and transition period is given in the notice and the recognized standards database.
- Change in Federal Payment and Collection Options (June 27): Moves payments to and collections by FDA, including MDUFA and Mammography Quality Standards Act (MQSA) fees, to electronic methods. From October 1, 2025, paper checks and similar options are generally no longer accepted, with some exceptions and waivers.
Device classification rules
Most of these write a classification decided earlier into the regulations; they do not mean any individual product was authorized that day. "Reclassification" changes a device type's class, and "proposed" marks a proposed rule open for comment.
- June 2: Classification: Device To Detect Bacterial Protease Activity in Chronic Wound Fluid
- June 2: Classification: Radiological Acquisition and/or Optimization Guidance System
- June 11: Reclassification: In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product (proposed)
- June 13: Classification: Cellular Analysis System for Multiplexed Antimicrobial Susceptibility Testing
- June 13: Classification: Clinical Mass Spectrometry Microorganism Identification and Differentiation System
- June 13: Classification: Device To Detect and Identify Fungal Nucleic Acids Directly in Respiratory Specimens
- June 13: Classification: Radiological Computer-Assisted Detection and Diagnosis Software
- June 26: Classification: Lysosomal Storage Disorder Newborn Screening Test System
- June 26: Classification: Muscular Dystrophy Newborn Screening Test
- June 26: Classification: Fluorescence In Situ Hybridization-Based Detection of Chromosomal Abnormalities From Patients With Hematologic Malignancies
- June 26: Classification: Herpes Simplex Virus Nucleic Acid-Based Assay for Central Nervous System Infections
- June 26: Classification: Cream for X-Ray Attenuation
Safety communications and other updates
- Import Alerts for Certain Olympus Medical Devices Manufactured in Japan - Letter to Health Care Providers (June 24): Explains to providers the import alerts that block future shipments of certain Olympus endoscopes, automated endoscope reprocessors and other devices from entering the U.S., issued over concerns about continuing quality system violations.
Also this month
- June 26: FDA withdrew its enforcement policy guidance for clinical electronic thermometers, first issued in November 2023.
Note: dates are FDA issue dates or Federal Register publication dates. Linked pages may now show a later version.
RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.
← All articles